INO
Price
$2.42
Change
-$0.05 (-2.03%)
Updated
Aug 28, 11:29 AM (EDT)
Capitalization
108.41M
PCSA
Price
$0.21
Change
-$0.00 (-0.00%)
Updated
Aug 28, 11:39 AM (EDT)
Capitalization
10.72M
Interact to see
Advertisement

INO vs PCSA

Header iconINO vs PCSA Comparison
Open Charts INO vs PCSABanner chart's image
Inovio Pharmaceuticals
Price$2.42
Change-$0.05 (-2.03%)
Volume$7.65K
Capitalization108.41M
Processa Pharmaceuticals
Price$0.21
Change-$0.00 (-0.00%)
Volume$500
Capitalization10.72M
INO vs PCSA Comparison Chart in %
Loading...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INO vs. PCSA commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INO is a Buy and PCSA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (INO: $2.46 vs. PCSA: $0.21)
Brand notoriety: INO: Notable vs. PCSA: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INO: 300% vs. PCSA: 20%
Market capitalization -- INO: $108.41M vs. PCSA: $10.72M
INO [@Biotechnology] is valued at $108.41M. PCSA’s [@Biotechnology] market capitalization is $10.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INO’s FA Score shows that 0 FA rating(s) are green whilePCSA’s FA Score has 1 green FA rating(s).

  • INO’s FA Score: 0 green, 5 red.
  • PCSA’s FA Score: 1 green, 4 red.
According to our system of comparison, both INO and PCSA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INO’s TA Score shows that 6 TA indicator(s) are bullish while PCSA’s TA Score has 3 bullish TA indicator(s).

  • INO’s TA Score: 6 bullish, 4 bearish.
  • PCSA’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, INO is a better buy in the short-term than PCSA.

Price Growth

INO (@Biotechnology) experienced а +32.97% price change this week, while PCSA (@Biotechnology) price change was +2.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.78%. For the same industry, the average monthly price growth was +15.45%, and the average quarterly price growth was +31.58%.

Industries' Descriptions

@Biotechnology (+2.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INO($108M) has a higher market cap than PCSA($10.7M). INO YTD gains are higher at: 38.202 vs. PCSA (-75.911). PCSA has higher annual earnings (EBITDA): -12.96M vs. INO (-84.73M). INO has more cash in the bank: 47.5M vs. PCSA (6.94M). PCSA has less debt than INO: PCSA (25.6K) vs INO (10.7M). INO has higher revenues than PCSA: INO (182K) vs PCSA (0).
INOPCSAINO / PCSA
Capitalization108M10.7M1,009%
EBITDA-84.73M-12.96M654%
Gain YTD38.202-75.911-50%
P/E RatioN/AN/A-
Revenue182K0-
Total Cash47.5M6.94M685%
Total Debt10.7M25.6K41,797%
FUNDAMENTALS RATINGS
INO: Fundamental Ratings
INO
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INOPCSA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bullish Trend 7 days ago
74%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 21 days ago
88%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPHRY0.800.02
+1.92%
Starpharma Holdings Ltd.
HPHTF11.39N/A
N/A
Hamamatsu Photonics
PEFDF0.64N/A
N/A
DELFI LTD
TTGXF0.03N/A
N/A
Trans Canada Gold Corp.
UPMKF29.85N/A
-0.01%
UPM-Kymmene Corp.

INO and

Correlation & Price change

A.I.dvisor indicates that over the last year, INO has been loosely correlated with AXON. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if INO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INO
1D Price
Change %
INO100%
+20.59%
AXON - INO
53%
Loosely correlated
+0.09%
KROS - INO
53%
Loosely correlated
+4.09%
ARRY - INO
52%
Loosely correlated
-5.54%
RPTX - INO
52%
Loosely correlated
+2.48%
ALNY - INO
42%
Loosely correlated
+0.66%
More

PCSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCSA has been loosely correlated with INO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PCSA jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCSA
1D Price
Change %
PCSA100%
-4.79%
INO - PCSA
38%
Loosely correlated
+20.59%
ONCO - PCSA
35%
Loosely correlated
-4.85%
MGX - PCSA
30%
Poorly correlated
-0.53%
EDIT - PCSA
28%
Poorly correlated
-2.20%
LVTX - PCSA
27%
Poorly correlated
+1.97%
More